A Multi-Center Study to Evaluate Subject Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Trifarotene (Primary)
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors Galderma Research & Development
Most Recent Events
- 07 May 2020 Status changed from active, no longer recruiting to completed.
- 29 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Apr 2019 New trial record